Zentalis Pharmaceuticals, Inc.
ZNTL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001725160
In the last 90 days, Zentalis Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 114 institutions reported holding it in 13F filings for Q2 2026, worth $228.9M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Zentalis Pharmaceuticals, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 120
- +25 vs. Q1 2021
- Shares held
- 40.1M
- +3.73M (+10.3%) vs. Q1 2021
- Total value
- $2.13B
- +$555.1M (+35.2%) vs. Q1 2021
- New holders
- 35
- 54 more added
- Sold out
- 10
- 19 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZNTL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 114 | $228.9M |
| Q1 2026 | 102 | $101.7M |
| Q4 2025 | 86 | $54.9M |
| Q3 2025 | 99 | $79.7M |
| Q2 2025 | 117 | $64.5M |
| Q1 2025 | 132 | $92.9M |
| Q4 2024 | 142 | $195.2M |
| Q3 2024 | 136 | $261.2M |
| Q2 2024 | 145 | $314.3M |
| Q1 2024 | 142 | $1.34B |
| Q4 2023 | 120 | $1.23B |
| Q3 2023 | 137 | $1.61B |
| Q2 2023 | 134 | $2.32B |
| Q1 2023 | 110 | $1.15B |
| Q4 2022 | 106 | $1.30B |
| Q3 2022 | 121 | $1.27B |
| Q2 2022 | 122 | $1.64B |
| Q1 2022 | 128 | $2.05B |
| Q4 2021 | 139 | $3.61B |
| Q3 2021 | 116 | $2.75B |
| Q2 2021 | 120 | $2.13B |
| Q1 2021 | 95 | $1.58B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Zentalis Pharmaceuticals, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| STRS Ohio | 3,800 | $202.0K | 0.00% | +400+11.8% | Added |
| Tower Research Capital LLC (TRC) | 3,084 | $164.0K | 0.00% | +1,640+113.6% | Added |
| FORA Capital, LLC | 2,692 | $143.0K | 0.03% | +2,692 | New |
| Ameritas Investment Partners, Inc. | 2,607 | $139.0K | 0.00% | +199+8.3% | Added |
| Royal Bank of Canada | 2,276 | $121.0K | 0.00% | −89−3.8% | Reduced |
| Nisa Investment Advisors, LLC | 1,680 | $89.0K | 0.00% | +1,680 | New |
| Great West Life Assurance Co | 1,165 | $62.0K | 0.00% | 00.0% | Unchanged |
| O'Shaughnessy Asset Management, LLC | 1,170 | $62.0K | 0.00% | +1,170 | New |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 1,098 | $58.0K | 0.00% | +122+12.5% | Added |
| Penserra Capital Management LLC | 940 | $50.0K | 0.00% | +25+2.7% | Added |
| State of Wyoming | 680 | $36.0K | 0.02% | +387+132.1% | Added |
| Macquarie Group Ltd | 533 | $28.0K | 0.00% | +533 | New |
| Cubist Systematic Strategies, LLC | 417 | $22.0K | 0.00% | +417 | New |
| UBS Group AG | 255 | $14.0K | 0.00% | +255 | New |
| Meeder Asset Management Inc | 118 | $6.00K | 0.00% | +118 | New |
| Quantbot Technologies LP | 103 | $5.00K | 0.00% | +103 | New |
| Daiwa Securities Group Inc. | 76 | $4.00K | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 45 | $2.00K | 0.00% | +3+7.1% | Added |
| Signaturefd, LLC | 16 | $1.00K | 0.00% | +16 | New |
| Carroll Financial Associates, Inc. | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Franklin Resources Inc | 0 | $0 | 0.00% | −327,197−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −175,140−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −64,718−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −58,256−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −44,993−100.0% | Sold out |
| Graticule Asia Macro Advisors LLC | 0 | $0 | 0.00% | −41,550−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −4,886−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −4,225−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −1,530−100.0% | Sold out |